Home LiteratureArticle Details
PMID: 18576316 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.

Arthritis and rheumatism ·Vol. 58 ·No. 7 ·2008-07-00 ·Pages 2120-30

Venigalla RK, Tretter T, Krienke S, Max R, Eckstein V, Blank N, Fiehn C, Ho AD, Lorenz HM

Abstract

CD4+,CD25high regulatory T (Treg) cells play a crucial role in the maintenance of self tolerance and prevention of organ-specific autoimmunity. The presence of many in vivo-preactivated CD4+,CD25++ T cells in patients with systemic lupus erythematosus (SLE) poses a difficulty in discriminating CD25++ activated T cells from CD25high Treg cells. To overcome this problem, we analyzed the phenotype and function of CD4+,CD25high,CD127(-/low) natural Treg (nTreg) cells isolated from the peripheral blood of patients with SLE. CD4+,CD25high,CD127(-/low) nTreg cells and CD4+,CD25- responder T (Tresp) cells from patients with SLE and normal donors were separated by fluorescence-activated cell sorting. Cell proliferation was quantified by 3H-thymidine incorporation, and immunophenotyping of the cells was done using FACScan. Comparable percentages of CD4+,CD25high,FoxP3+ T cells were observed in patients with SLE and normal donors. Proliferation of SLE nTreg cells sorted into the subset CD4+,CD25high,CD127(-/low) was significantly decreased compared with that of SLE nTreg cells sorted into the subset CD4+,CD25high (mean +/- SEM 2,223 +/- 351 counts per minute versus 9,104 +/- 1,720 cpm, respectively), while in normal donors, these values were 802 +/- 177 cpm and 2,028 +/- 548 cpm, respectively, confirming that effector cell contamination was reduced. Notably, the suppressive activity of nTreg cells was intact in all groups. However, CD4+,CD25- Tresp cells isolated from patients with active SLE were significantly less sensitive than those from patients with inactive SLE to the suppressive function of autologous or normal donor CD4+,CD25high,CD127(-/low) nTreg cells. Furthermore, a significant inverse correlation was observed between the extent of T cell regulation in suppressor assays and the level of lupus disease activity. This study is the first to show that, in human SLE, impaired sensitivity of Tresp cells to the suppressive effects of a comparably functional, highly purified nTreg cell population leads to a defective suppression of T cell proliferation in active SLE. Studies aiming to define the mechanisms leading to Tresp cell resistance might help in the development of highly specific, alternative immunotherapeutic tools for the control of systemic autoimmune diseases such as SLE.

MeSH Terms
Adult Aged CD4 Antigens Case-Control Studies Cell Proliferation Female Forkhead Transcription Factors/metabolism Humans Interleukin-2 Receptor alpha Subunit Interleukin-7 Receptor alpha Subunit Lupus Erythematosus, Systemic/immunology,physiopathology Male Middle Aged Phenotype Severity of Illness Index T-Lymphocytes, Regulatory/immunology
Chemicals
CD4 Antigens FOXP3 protein, human Forkhead Transcription Factors Interleukin-2 Receptor alpha Subunit Interleukin-7 Receptor alpha Subunit
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Venigalla Ram Kumar Chowdary
University of Heidelberg, Heidelberg, Germany.
Tretter Theresa
Krienke Stefan
Max Regina
Eckstein Volker
Blank Norbert
Fiehn Christoph
Ho Anthony Dick
Lorenz Hanns-Martin
Article Info
Journal
Arthritis and rheumatism
Abbr.
Arthritis Rheum
ISSN
0004-3591
Published
2008-07-00
Pages
2120-30
Language
English
Region
United States
NLM ID
0370605
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com